#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Erythema multiforme Neuropathy peripheral Cerebral haemorrhage Follicular lymphoma stage I Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Lymphatic malformation Transitional cell carcinoma Advanced systemic mastocytosis Diffuse large B-cell lymphoma refractory Heritable pulmonary arterial hypertension Hairy cell leukaemia Head and neck cancer White matter lesion Hereditary ataxia Epidermolysis bullosa More trials…

    Learn about Rare Diseases

    Gaucher’s disease type III – Diagnostics Netherton’s syndrome – Life with Disease Progressive supranuclear palsy – Trials in Disease Medulloblastoma – Trials in Disease Marginal zone lymphoma – Trials in Disease Familial amyotrophic lateral sclerosis – Basic Information Hereditary optic atrophy – Life with Disease SAPHO syndrome – Treatment Testicular leiomyosarcoma – Trials in Disease Isodicentric chromosome 15 syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Idarubicin Simoctocog Alfa Lonapegsomatropin Ly3437943 Sodium Dexchlorpheniramine Maleate Aliskiren Remimazolam Piromelatine 99MTC-EUK-(SO3)CY5-MAS3 Vx-522 Tirbanibulin Aptamer-4Ft Progesterone, Micronised Rugonersen Bhv-7000 Bezafibrate Belzupacap Sarotalocan Mesalazine DCC-3084 Nofazinlimab More therapies…

    Learn about Your Condition

    Pneumothorax Overweight Vulvar dysplasia Atrophic vulvovaginitis Pancreatic carcinoma recurrent Ovarian cancer metastatic Mantle cell lymphoma stage II Systemic lupus erythematosus Tympanic membrane perforation Liver transplant Epstein-Barr virus infection Prolymphocytic leukaemia Hypopituitarism Small intestine adenocarcinoma Angiosarcoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of BMS-986504 alone or in drug combination in adults with advanced or metastatic solid tumors with MTAP deletion

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • 2-[4-[4-(AMINOMETHYL)-1-OXO-2H-PHTHALAZIN-6-YL]-2-METHYLPYRAZOL-3-YL]-4-CHLORO-6-CYCLOPROPYLOXY-3-FLUOROBENZONITRILE
    • Carboplatin
    • Cisplatin
    Belgium France Germany Ireland Italy Norway +1

  • Patient‑controlled remimazolam, alfentanil and midazolam sedation for outpatients undergoing colonoscopy: safety, efficacy and satisfaction study

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Midazolam
    • Remimazolam
    Denmark

  • Safety and Tolerability Study of Subcutaneous Pegtibatinase in Adults and Children with Classical Homocystinuria (Phase 1/2)

    Not yet recruiting

    2 1 1
    France

  • Intranasal remestemcel therapy for newborns with hypoxic‑ischemic brain injury: a phase II placebo‑controlled trial

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Brain injury
    Investigated Drugs:
    • Remestemcel
    The Netherlands

  • Phase 2/3 study of telisotuzumab adizutecan with drug combination versus standard care in adults with first‑line metastatic pancreatic ductal adenocarcinoma

    Not yet recruiting

    4 1 1 1
    Investigated Drugs:
    • Irinotecan Hydrochloride
    • Calcium Folinate
    • Fluorouracil
    Austria France Germany Italy Portugal Spain

  • Study of Camizestrant and Abemaciclib in Patients with ER‑positive HER2‑negative Metastatic Breast Cancer Who Show Rising ctDNA

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Abemaciclib
    • Camizestrant
    France
Previous Page
1 … 682 683 684 685 686 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!